August 7th 2024
Why is it important for organizations to set long-term goals when planning for a sustainable future?
July 24th 2024
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
July 17th 2024
How teamwork among safety-net healthcare providers and pharma can make the difference.
June 7th 2024
Causal mediation analysis sought to determine how public hesitancy plays a role in the government procurement of certain vaccines.
May 30th 2024
These advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.
Recognizing Critical Gaps in Today's Supply Chain for Temperature-Sensitive Drugs
The potential of translational research for new medicines
The proposed federal National Center for Advancing Translational Sciences holds promise for drug development
The Battle for Control of Specialty Drugs
Specialty distributors, specialty pharmacies and healthcare providers are all competing for a dominant position in drug delivery and reimbursement
ACOs and Their Impact on Pharma
Accountable care organizations will seek ‘economic and clinical value’ for pharmaceuticals
Fix the Drug Shortage Problem- Now
Drug shortages are opening the door to price gouging
Hospital pharmacies need to be vigilant in ensuring safe supplies of scarce drugs
Bloodied But Unbowed on the Personalized Medicine Battlefront
Do Dendreon’s troubles with over-optimistic sales forecasts put a cap on the promise of personalized medicine?
The Alternative Universes of Big PBMs and Little Independent Pharmacies
FDA: Pathway to Global Product Safety and Quality
After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs
Industry and FDA can—and must—do more to protect global pharmaceutical supply chains
New Commercial Model: Fact Vs. Fiction
Belief that today’s commercial model is “broken” elicits a wide range of responses from industry
Fixing the Disjointed World of Marketing Operations
A supply chain perspective on marketing operations can reduce cost and complexity while improving results
Back to the Future With Track-and-Trace
Pharma 2020: Supplying the Future
Redesigning supply chains could change the shape of bio/pharma
REMS Drives Manufacturer-Specialty Pharmacy Relationships
Specialty pharmacies are competing to position themselves as the best partners for manufacturers dealing with high-touch, high-risk products
Bringing New Science, and New Partners, Into the Drug Development Process
Today’s evolving healthcare environment calls for more collaboration in bringing drugs to market
The Role of Health Coaching in Adherence and Supporting Patients 'Beyond the Pill'
GSK invests in online resources to address ‘the whole patient’
Health Reform Includes Research and Prevention
The Rising Importance of Observational Research
International efforts to standardize guidelines for observational research could move the entire field forward
Are Pharma Brands Worth Protecting?
Forces of Change for Pharmaceutical Wholesalers
Just as the pharma industry is feeling price and margin pressure, so are wholesalers in today’s healthcare marketplace
How to Think About Companion Diagnostics
Both promise and peril exist for drugmakers in working with diagnostic tests to commercialize new medications or refine the applicability of existing ones
Mid-Course Corrections for REMS
The Time Is Right to Reform Your Approach to Managed Care
Not all managed care plans have the same influence on overall prescribing behavior, and not all geographies operate the same way
Deloitte 2010 Survey of Health Care Consumers
More personal control over healthcare and the desire for more access to information drive consumer attitudes
Today's Sales Reps: Medical Professionals, Order Takers, Delivery Staff--or Something Else?
Court rulings begin to swing toward categorizing pharma reps as hourly workers
Small Distributors Serve a Vital Role in the Pharmaceutical Distribution Supply Chain
Spotlight on the EMD Serono Specialty Digest, 6th Edition
The biopharma company’s annual report provides clarity to a confusing marketplace
Retail Pharmacies and the Health and Wellness Renaissance
Following are excerpts from the keynote presentation of Steven C. Anderson, president and CEO of the National Assn. of Chain Drug Stores, at its annual meeting, Palm Beach, FL, Apr. 25.
Follow the Money... Where Healthcare Policy is Headed
CMS will be changing reimbursement practices regardless of how healthcare reform plays out